Question

_{Explain the changes in pricing and transparency over the course of Medicare.}

Answer 1

The centres for medicare and medicaid services(CMS) has proposed new strategies to improve drug affordability in prescription and has released a request for information on the price transparency regulations.

In 2019 The Physicians Fee Schedule has adopted a new pricing model for part B drugs. It has made the prices that the patient pay for the prescription reflects true cost.

CMS has requested to promote transparency about the cost of health care services for beneficiaries. The changes proposed by CMS tie up with patients over paper work initiative and other initiatives to improve data sharing, price transparency, and digital administration with public payer programs.

The proposed changes to physicians fee schedule and quality payment program face those problems head on, by streamlining the documentation requirements to focus on patient care so that the medicare can take advantage of latest technologies to get the quality care the individual requires.